NIA
EDIT icon

NIA Impact Advisors’s Editas Medicine EDIT Stock Holding History

NIA Impact Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,931
Closed -$124K – 61
2022
Q4 		$124K Sell
13,931
-10,488
-43% -$115K 0.07% 56
2022
Q3 		$299K Sell
24,419
-70,284
-74% -$1.1M 0.18% 56
2022
Q2 		$1.12M Sell
94,703
-59,551
-39% -$798K 0.67% 51
2022
Q1 		$2.93M Buy
154,254
+65,381
+74% +$1.22M 1.42% 27
2021
Q4 		$1.54M Buy
88,873
+6,639
+8% +$229K 0.82% 40
2021
Q3 		$3.38M Buy
82,234
+11,870
+17% +$650K 1.44% 29
2021
Q2 		$3.98M Buy
70,364
+5,280
+8% +$195K 1.94% 20
2021
Q1 		$2.73M Buy
65,084
+10,469
+19% +$596K 1.48% 31
2020
Q4 		$4.9M Buy
+54,615
New +$2.24M 2.55% 15

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

NIA Impact Advisors's EDIT Position: Q1 2023 in Review

NIA Impact Advisors sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 13,931 shares — an estimated $124K sold.

NIA Impact Advisors first reported a position in EDIT in Q4 2020 and held it in 9 quarters. The position peaked at $4.9M in Q4 2020. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • NIA Impact Advisors reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • NIA Impact Advisors sold 13,931 Editas Medicine shares in Q1 2023, an estimated $124K.
  • NIA Impact Advisors first reported a position in Editas Medicine in Q4 2020 and held it in 9 quarters.
  • NIA Impact Advisors's Editas Medicine position peaked at $4.9M in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on NIA Impact Advisors's 13F filing for Q1 2023, filed 3 May 2023.